Publicacións nas que colabora con Patricia Fernández Robredo (42)

2024

  1. Could Children’s Myopization Have Been Avoided during the Pandemic Confinement? The Conjunctival Ultraviolet Autofluorescence (CUVAF) Biomarker as an Answer

    Biomedicines, Vol. 12, Núm. 2

2023

  1. Matrix Metalloproteinase 13 Is Associated with Age-Related Choroidal Neovascularization

    Antioxidants, Vol. 12, Núm. 4

  2. Suitability of machine learning for atrophy and fibrosis development in neovascular age-related macular degeneration

    Acta Ophthalmologica

2022

  1. A Cross-Sectional Observational Study of the Relationship between Outdoor Exposure and Myopia in University Students, Measured by Conjunctival Ultraviolet Autofluorescence (CUVAF)

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  2. Matrix Metalloproteinase 10 Contributes to Choroidal Neovascularisation

    Biomedicines, Vol. 10, Núm. 7

  3. The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world

    Acta ophthalmologica, Vol. 100, Núm. 2, pp. e521-e531

2021

  1. A randomized study of nutritional supplementation in patients with unilateral wet age-related macular degeneration

    Nutrients, Vol. 13, Núm. 4

  2. A safe gdnf and gdnf/bdnf controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells: Potential usefulness in degenerative retinal pathologies

    Pharmaceuticals, Vol. 14, Núm. 1, pp. 1-24

  3. Anti-inflammatory and anti-oxidative synergistic effect of vitamin d and nutritional complex on retinal pigment epithelial and endothelial cell lines against age-related macular degeneration

    Nutrients, Vol. 13, Núm. 5

  4. Evaluation of macular retinal vessels and histological changes in two cases of covid-19

    Biomedicines, Vol. 9, Núm. 11

  5. Mitochondrial dysfunction and endoplasmic reticulum stress in age related macular degeneration, role in pathophysiology, and possible new therapeutic strategies

    Antioxidants, Vol. 10, Núm. 8

  6. Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

    Acta ophthalmologica, Vol. 99, Núm. 8, pp. 861-870

2020

  1. A higher proportion of eicosapentaenoic acid (EPA) when combined with docosahexaenoic acid (DHA) in omega-3 dietary supplements provides higher antioxidant effects in human retinal cells

    Antioxidants, Vol. 9, Núm. 9, pp. 1-16

  2. Genetic and environmental factors related to the development of myopic maculopathy in Spanish patients

    PloS one, Vol. 15, Núm. 7, pp. e0236071

  3. Vitamin d protects against oxidative stress and inflammation in human retinal cells

    Antioxidants, Vol. 9, Núm. 9, pp. 1-18

2019

  1. Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization

    Molecular Therapy - Methods and Clinical Development, Vol. 15, pp. 403-417

2018

  1. Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration

    Acta Ophthalmologica, Vol. 96, Núm. 2, pp. e201-e212

  2. Novel association of high C-reactive protein levels and A69S at risk alleles in wet age-related macular degeneration women

    Frontiers in Immunology, Vol. 9, Núm. AUG

2017

  1. Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery

    Molecular Therapy - Nucleic Acids, Vol. 9, pp. 1-11

2016

  1. Evaluation of 10 AMD Associated polymorphisms as a cause of choroidal neovascularization in highly myopic eyes

    PLoS ONE, Vol. 11, Núm. 9